Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
Alfons JM van den Eertwegh(Amsterdam UMC Location VUmc), Jurjen Versluis(Amsterdam UMC Location VUmc), H. Pieter van den Berg(Amsterdam UMC Location VUmc), Saskia J. Santegoets(Amsterdam UMC Location VUmc), R. Jeroen A. van Moorselaar(Amsterdam UMC Location VUmc), Tim M. van der Sluis(Amsterdam UMC Location VUmc), Helen Gall(Amsterdam UMC Location VUmc), Thomas C. Harding(Genesys (United States)), Karin Jooss(Genesys (United States)), Israel Lowy, Herbert M. Pinedo(Amsterdam UMC Location VUmc), Rik J. Scheper(Vrije Universiteit Amsterdam), Anita G.M. Stam(Vrije Universiteit Amsterdam), B. Mary E. von Blomberg(Vrije Universiteit Amsterdam), Tanja D. de Gruijl(Amsterdam UMC Location VUmc), Kristen Hege(Genesys (United States)), Natalie Sacks(Genesys (United States)), Winald R. Gerritsen(Amsterdam UMC Location VUmc)
Cited by 357
Abstract
Related Papers
No related papers found
Powered by citation graph analysis